.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
UBS
Johnson and Johnson
AstraZeneca
Covington
Julphar
Accenture
Medtronic
Cipla
Queensland Health

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071295

« Back to Dashboard
NDA 071295 describes ATROPINE, which is a drug marketed by Abbvie, Us Army, Akorn, and Hospira, and is included in seven NDAs. Additional details are available on the ATROPINE profile page.

The generic ingredient in ATROPINE is atropine sulfate. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.

Summary for 071295

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 2MG SULFATE/0.7ML
Approval Date:Jan 30, 1987TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Citi
Fish and Richardson
Cipla
US Department of Justice
QuintilesIMS
Harvard Business School
Dow
US Army
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot